Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06928545 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MagDI U.S. Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 5 to 6v5
  2. Study sites: 4 to 5v4
  3. Study sites: 3 to 4v3
  4. Primary endpoint revised
    • Enrollment target: 80 to 106
    • Study sites: 1 to 3
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to-side duodeno-ileal anastomoses.
Trial Details
NCT Number NCT06928545
Lead Sponsor GT Metabolic Solutions, Inc.
Conditions
(from sponsor)		 Anastomosis, Surgical, Internal Hernia, Bowel Obstruction
Related terms Internal Hernia, Intestinal Obstruction
Enrollment 106 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov